Literature DB >> 2835401

Hepatic tumours induced by anabolic steroids in an athlete.

T M Creagh1, A Rubin, D J Evans.   

Abstract

A fatal rupture of an hepatic tumour occurred in an athlete who had been taking anabolic steroids for several years as an aid to body building. The case illustrates the hazards of non-therapeutic androgen administration, and emphasises the need for athletes to be made clear of the disturbances to gonadal function, liver structure and function, and the threat to life.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2835401      PMCID: PMC1141472          DOI: 10.1136/jcp.41.4.441

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

Review 1.  Hepatic neoplasms associated with contraceptive and anabolic steroids.

Authors:  K G Ishak
Journal:  Recent Results Cancer Res       Date:  1979

2.  Long-term survival with tumor regression in androgen-induced liver tumors.

Authors:  G W McCaughan; M J Bilous; N D Gallagher
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

3.  Letter: hepatoma associated with androgenic steroids.

Authors:  P P Anthony
Journal:  Lancet       Date:  1975-03-22       Impact factor: 79.321

4.  Androgen related primary hepatic tumors in non-Fanconi patients.

Authors:  D Westaby; B Portmann; R Williams
Journal:  Cancer       Date:  1983-05-15       Impact factor: 6.860

5.  Androgen-induced hepatoma.

Authors:  G C Farrell; D E Joshua; R F Uren; P J Baird; K W Perkins; H Kronenberg
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

6.  Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosterone therapy: possible relationships of these changes to the developement of peliosis hepatis and liver tumours.

Authors:  F J Paradinas; T B Bull; D Westaby; I M Murray-Lyon
Journal:  Histopathology       Date:  1977-07       Impact factor: 5.087

  6 in total
  20 in total

Review 1.  Enhancement of athletic performance with drugs. An overview.

Authors:  J C Wagner
Journal:  Sports Med       Date:  1991-10       Impact factor: 11.136

2.  Near-fatal spontaneous hepatic rupture associated with anabolic androgenic steroid use: a case report.

Authors:  J J Patil; B O'Donohoe; C F Loyden; D Shanahan
Journal:  Br J Sports Med       Date:  2007-01-15       Impact factor: 13.800

Review 3.  Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature.

Authors:  A Kosaka; H Takahashi; Y Yajima; M Tanaka; K Okamura; R Mizumoto; K Katsuta
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 4.  Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids.

Authors:  C E Yesalis; J E Wright; M S Bahrke
Journal:  Sports Med       Date:  1989-09       Impact factor: 11.136

5.  Proportionate mortality of Italian soccer players: is amyotrophic lateral sclerosis an occupational disease?

Authors:  Stefano Belli; Nicola Vanacore
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 6.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 7.  Exercise in the prevention and treatment of cancer. An update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1993-04       Impact factor: 11.136

Review 8.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

9.  Androgen associated hepatocellular carcinoma with an aggressive course.

Authors:  D Gleeson; M J Newbould; P Taylor; R F McMahon; B C Leahy; T W Warnes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 10.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.